The Massive Financial Penalty of Ignoring Microbial Risk

The government’s final brief for the cannabis rescheduling hearing focuses on currently accepted medical use, a scientific and medical analysis, and the opposition’s ‘so-called experts.’

Part III of ‘The Cost of Doing Nothing’ series examines how airborne pathogen pressure and compliance testing turn microbial outbreaks into immediate, measurable losses, ranging from hundreds of thousands to millions of dollars annually – losses set to grow as Schedule III and export markets raise the testing bar.

A bipartisan quartet of lawmakers sent a letter to Trump and three cabinet members, asking for clarity on the federal policy for medical cannabis.

The state’s 45,000-plus medical cannabis patients could receive dispensary products through federal or private mail carriers under the proposed rule change.

A majority of registered voters plan to reject a November ballot question that would backtrack the state’s adult-use legalization laws, according to a new poll.